Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by New York Times in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: New York Times’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 2:44 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000071691-26-000034
| Line item | For the Quarters Ended / June 30, 2026 | For the Quarters Ended / June 30, 2025 | For the Six Months Ended / June 30, 2026 | For the Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Operating costs | ||||
| Cost of revenue (excluding depreciation and amortization) | 367,841 | 338,779 | 730,777 | 673,416 |
| Sales and marketing | 85,509 | 69,165 | 162,772 | 135,124 |
| Product development | 70,350 | 63,940 | 140,543 | 130,479 |
| General and administrative | 85,767 | 82,552 | 172,219 | 162,465 |
| Depreciation and amortization | 21,123 | 21,396 | 41,686 | 42,774 |
| Generative AI Litigation Costs | 4,628 | 3,490 | 8,840 | 7,887 |
| Multiemployer pension plan liability adjustments | 9,219 | — | 9,219 | 4,453 |
Item 1. Financial Statements
FAQ
- What is New York Times's R&D?
- New York Times (NYT) reported R&D of $70.35M in Q2 2026.
- How has New York Times's R&D changed year-over-year?
- New York Times's R&D increased by 10.0% year-over-year, from $63.94M to $70.35M.
- What is the long-term trend for New York Times's R&D?
- Over 4 years (2021 to 2025), New York Times's R&D has grown at a -1.4% compound annual growth rate (CAGR), from $280.15M to $264.35M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about New York Times's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude